{
    "code": 0,
    "data": [
        {
            "co_code": 4325,
            "bse_code": 524715,
            "isin": "INE044A01036",
            "ann_type": "General_Announcements",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "Newspaper Advertisement for special window for transfer of Physical Shares",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e1283f4f-f9dc-42a5-b24b-a986da9222c9.pdf",
            "news_date": "2026-02-06 17:38:09"
        },
        {
            "sym": "SUNPHARMA",
            "disp": "Sun Pharmaceutical",
            "bse_code": 524715,
            "isin": "INE044A01036",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Q3FY26 Earnings Call Transcript",
            "news_id": "a4a44f0f-4e6c-4928-b722-d554598967d4",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1082d0ab-d6fb-40f5-873e-d7301397cd05.pdf",
            "news_date": "2026-02-04 19:48:05",
            "seo": "sun-pharmaceutical-ltd",
            "ltp": 1711.1,
            "ch": 3.2999999999999545,
            "pch": 0.19323105750087566,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3351,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 4325,
            "bse_code": 524715,
            "isin": "INE044A01036",
            "ann_type": "General_Announcements",
            "descriptor": "Earnings Call Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Q3FY26 Earnings Call Transcript",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1082d0ab-d6fb-40f5-873e-d7301397cd05.pdf",
            "news_date": "2026-02-04 19:48:05"
        },
        {
            "co_code": 4325,
            "bse_code": 524715,
            "isin": "INE044A01036",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
            "news_body": "Intimation of Schedule of Analyst/Institutional Investor Meeting",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ae295905-fd41-4699-a05d-0b7e9531d7ec.pdf",
            "news_date": "2026-02-03 18:28:11"
        },
        {
            "co_code": 4325,
            "bse_code": 524715,
            "isin": "INE044A01036",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Sustainability Report For The Financial Year 2024-25",
            "news_body": "Sustainability Report for FY 2024-25",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=26df0b53-76ff-41b0-bfef-cb37e833ef5b.pdf",
            "news_date": "2026-02-02 19:05:48"
        },
        {
            "co_code": 4325,
            "bse_code": 524715,
            "isin": "INE044A01036",
            "ann_type": "General_Announcements",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "Newspaper Advertisements for Unaudited Financial Results for the quarter and nine months ended 31 December 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=afd474d9-6641-40e1-92a6-a4e42035eb7a.pdf",
            "news_date": "2026-02-01 13:31:44"
        },
        {
            "sym": "SUNPHARMA",
            "disp": "Sun Pharmaceutical",
            "bse_code": 524715,
            "isin": "INE044A01036",
            "descriptor": "General",
            "cat": "Audio",
            "caption": "Q3FY26 Earnings Call Audio Recording",
            "news_body": "Q3FY26 Earnings Call audio recording",
            "news_id": "4620c544-0021-4550-af07-aeec6c5da570",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=fe19d494-870f-4508-af81-37b62c0dc0b8.pdf",
            "news_date": "2026-01-31 20:21:02",
            "seo": "sun-pharmaceutical-ltd",
            "ltp": 1711.1,
            "ch": 3.2999999999999545,
            "pch": 0.19323105750087566,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3351,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 4325,
            "bse_code": 524715,
            "isin": "INE044A01036",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Q3FY26 Earnings Call Audio Recording",
            "news_body": "Q3FY26 Earnings Call audio recording",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=fe19d494-870f-4508-af81-37b62c0dc0b8.pdf",
            "news_date": "2026-01-31 20:21:02"
        },
        {
            "co_code": 4325,
            "bse_code": 524715,
            "isin": "INE044A01036",
            "ann_type": "General_Announcements",
            "descriptor": "Change in Directorate",
            "caption": "Announcement under Regulation 30 (LODR)-Change in Directorate",
            "news_body": "Board of Directors of the Company has approved the re-appointment of Dr. Pawan Goenka as Independent director for a second term of five years effective from 21 May 2026 and noted the cessation of Ms. Rama Bijapurkar as a Independent director upon completion of her first term on 20 May 2026.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=47b28d49-1b8b-46ff-9cef-f43e165116de.pdf",
            "news_date": "2026-01-31 17:39:43"
        },
        {
            "co_code": 4325,
            "bse_code": 524715,
            "isin": "INE044A01036",
            "ann_type": "Outcome",
            "descriptor": "Dividend",
            "caption": "Corporate Action-Board approves Dividend",
            "news_body": "Board has approved the interim dividend for FY 2025-26",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=95ef1123-6c24-4f2c-9383-bee430383fc0.pdf",
            "news_date": "2026-01-31 14:30:33"
        },
        {
            "sym": "SUNPHARMA",
            "disp": "Sun Pharmaceutical",
            "bse_code": 524715,
            "isin": "INE044A01036",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Financial Results For The Quarter And Nine Months Ended 31 December 2025",
            "news_body": "Unaudited Financial Results for the quarter and nine months ended 31 December 2025",
            "news_id": "af69f8f3-dc5b-42ba-a5c5-1516cb437c66",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f98cd836-0498-41d3-835b-bd611455ba9d.pdf",
            "news_date": "2026-01-31 14:26:50",
            "seo": "sun-pharmaceutical-ltd",
            "ltp": 1711.1,
            "ch": 3.2999999999999545,
            "pch": 0.19323105750087566,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3351,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 4325,
            "bse_code": 524715,
            "isin": "INE044A01036",
            "ann_type": "Outcome",
            "descriptor": "Financial Results",
            "caption": "Unaudited Financial Results For The Quarter And Nine Months Ended 31 December 2025",
            "news_body": "Unaudited Financial Results for the quarter and nine months ended 31 December 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f98cd836-0498-41d3-835b-bd611455ba9d.pdf",
            "news_date": "2026-01-31 14:26:50"
        },
        {
            "co_code": 4325,
            "bse_code": 524715,
            "isin": "INE044A01036",
            "ann_type": "General_Announcements",
            "descriptor": "Press Release / Media Release",
            "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release",
            "news_body": "Press release regarding intimation of DCGI approval to manufacture and market generic semaglutide injection in India for chronic weight management",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=35fc63fc-6317-425f-9194-c3cd3863254c.pdf",
            "news_date": "2026-01-23 08:21:31"
        },
        {
            "co_code": 4325,
            "bse_code": 524715,
            "isin": "INE044A01036",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
            "news_body": "Sun Pharma to announce third quarter results earnings call scheduled on Saturday 06.30 pm IST 31 January 2026\r\n",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=69355f9c-27ac-4c30-a1b0-e2b49087fa9b.pdf",
            "news_date": "2026-01-21 16:52:11"
        },
        {
            "co_code": 4325,
            "bse_code": 524715,
            "isin": "INE044A01036",
            "ann_type": "Intimation",
            "descriptor": "Record Date",
            "caption": "Intimation Of The Record Date For The Purpose Of The Interim Dividend For FY 2025-26 Is 05 February 2026",
            "news_body": "The Record date for the purpose of Interim Dividend for FY 2025-26 is 05 February 2026",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c105104c-6f24-40a0-9f54-06377a02ed08.pdf",
            "news_date": "2026-01-20 18:59:15"
        },
        {
            "co_code": 4325,
            "bse_code": 524715,
            "isin": "INE044A01036",
            "ann_type": "Intimation",
            "descriptor": "Board Meeting",
            "caption": "Board Meeting Intimation for Approval Of Financial Results For The Quarter And Nine Months Ended 31 December 2025 And The Interim Dividend For FY 2025-26",
            "news_body": "Sun Pharmaceutical Industries Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 31/01/2026 inter alia to consider and approve financial results for the quarter and nine months ended 31 December 2025 and the Interim Dividend for FY 2025-26",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b4ba0ce7-89ba-4c01-b8ae-cb9f86c950b8.pdf",
            "news_date": "2026-01-20 18:48:49"
        },
        {
            "co_code": 4325,
            "bse_code": 524715,
            "isin": "INE044A01036",
            "ann_type": "General_Announcements",
            "descriptor": "GENERAL",
            "caption": "Rumour verification - Regulation 30(11)",
            "news_body": "Response to Rumour verification letter from BSE",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6f33d9f2-55ff-470d-b4ab-b50e255d246b.pdf",
            "news_date": "2026-01-19 12:46:06"
        },
        {
            "co_code": 4325,
            "bse_code": 524715,
            "isin": "INE044A01036",
            "ann_type": "General",
            "descriptor": "Clarification",
            "caption": "Clarification sought from Sun Pharmaceutical Industries Ltd",
            "news_body": "The Exchange has sought clarification from Sun Pharmaceutical Industries Ltd on January 19 2026 with reference to news appeared in https://www.news18.com/ dated January 19 2026 quoting \"Sun Pharma Eyes Stronger US Presence With USD 10 Billion Organon Acquisition\"<BR><BR>The reply is awaited.",
            "file_url": "",
            "news_date": "2026-01-19 10:55:21"
        },
        {
            "co_code": 4325,
            "bse_code": 524715,
            "isin": "INE044A01036",
            "ann_type": "General_Announcements",
            "descriptor": "Press Release / Media Release",
            "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release",
            "news_body": "Press Release",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=08817f40-0386-46c4-8c55-9556e2e44513.pdf",
            "news_date": "2026-01-15 22:52:04"
        },
        {
            "co_code": 4325,
            "bse_code": 524715,
            "isin": "INE044A01036",
            "ann_type": "General",
            "descriptor": "Disclosures under Reg. 29(1) of SEBI (SAST) Regulations 2011",
            "caption": "Disclosures under Reg. 29(1) of SEBI (SAST) Regulations 2011",
            "news_body": "The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Life Insurance Corporation of India",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=48184219_AD41_423D_82AB_63E0EDAD0DF0_144144.pdf",
            "news_date": "2026-01-14 14:41:50"
        },
        {
            "co_code": 4325,
            "bse_code": 524715,
            "isin": "INE044A01036",
            "ann_type": "General_Announcements",
            "descriptor": "Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
            "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
            "news_body": "Intimation regarding Certificate of Compliance",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=79dcb4a5-826f-42b0-a9b8-f1c539bf93f7.pdf",
            "news_date": "2026-01-09 19:46:37"
        },
        {
            "co_code": 4325,
            "bse_code": 524715,
            "isin": "INE044A01036",
            "ann_type": "Intimation",
            "descriptor": "Closure of Trading Window",
            "caption": "Closure of Trading Window",
            "news_body": "Closure of Trading Window",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=69723357-e542-47e8-addb-0cb0df0e819c.pdf",
            "news_date": "2025-12-29 16:37:26"
        },
        {
            "sym": "SUNPHARMA",
            "disp": "Sun Pharmaceutical",
            "bse_code": 524715,
            "isin": "INE044A01036",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "SPIL Investor Presentation -Dec 2025",
            "news_id": "fc6a41dc-b184-4414-ad54-9b57d768b24e",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e01bfcbf-aaae-4101-a746-c13ec04f062e.pdf",
            "news_date": "2025-12-26 14:51:31",
            "seo": "sun-pharmaceutical-ltd",
            "ltp": 1711.1,
            "ch": 3.2999999999999545,
            "pch": 0.19323105750087566,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3351,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 4325,
            "bse_code": 524715,
            "isin": "INE044A01036",
            "ann_type": "General_Announcements",
            "descriptor": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "SPIL Investor Presentation -Dec 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e01bfcbf-aaae-4101-a746-c13ec04f062e.pdf",
            "news_date": "2025-12-26 14:51:31"
        },
        {
            "co_code": 4325,
            "bse_code": 524715,
            "isin": "INE044A01036",
            "ann_type": "General_Announcements",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "Newspaper Advertisement",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=43cc7492-7524-48fb-a6e2-ad0c8d8a4bf4.pdf",
            "news_date": "2025-12-23 13:10:34"
        },
        {
            "co_code": 4325,
            "bse_code": 524715,
            "isin": "INE044A01036",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 - US FDA Determines Baska Facility Inspection Classification As OAI",
            "news_body": "US FDA determines Baska facility inspection classification as OAI",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9253902b-2bcb-4cae-907c-c21deeec6730.pdf",
            "news_date": "2025-12-18 08:25:35"
        },
        {
            "co_code": 4325,
            "bse_code": 524715,
            "isin": "INE044A01036",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Intimation Under Regulation 30 - Approval Of Proposal For Greenfield Project",
            "news_body": "Intimation under Regulation 30 - Approval of proposal for Greenfield Project",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e0f039ff-4939-46df-8dff-270aee2446fe.pdf",
            "news_date": "2025-12-02 23:08:43"
        },
        {
            "co_code": 4325,
            "bse_code": 524715,
            "isin": "INE044A01036",
            "ann_type": "General_Announcements",
            "descriptor": "Press Release / Media Release",
            "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release",
            "news_body": "Sun Pharma introduces Ilumya in India for the treatment of moderate-to-severe Plaque Psoriasis.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6a603820-f14c-4e7a-a08c-167e6cdd93cd.pdf",
            "news_date": "2025-12-01 09:11:37"
        },
        {
            "co_code": 4325,
            "bse_code": 524715,
            "isin": "INE044A01036",
            "ann_type": "General_Announcements",
            "descriptor": "Press Release / Media Release",
            "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release",
            "news_body": "Press Release",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d6c25c7f-9456-421d-9213-0fe7cd989208.pdf",
            "news_date": "2025-11-26 10:29:13"
        },
        {
            "co_code": 4325,
            "bse_code": 524715,
            "isin": "INE044A01036",
            "ann_type": "General_Announcements",
            "descriptor": "Scheme of Arrangement",
            "caption": "Announcement under Regulation 30 (LODR)-Scheme of Arrangement",
            "news_body": "Intimation about Effective Date of the Composite Scheme of Arrangement",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=91910c5f-4a6a-4694-9e9f-284c980e5174.pdf",
            "news_date": "2025-11-22 13:46:37"
        },
        {
            "co_code": 4325,
            "bse_code": 524715,
            "isin": "INE044A01036",
            "ann_type": "General_Announcements",
            "descriptor": "Press Release / Media Release",
            "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release",
            "news_body": "AstraZeneca Pharma India and Sun Pharma partner to help patients living with Hyperaklaemia in India",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=737de599-5d69-4ff6-b7c8-360d68676c56.pdf",
            "news_date": "2025-11-17 16:05:34"
        },
        {
            "co_code": 4325,
            "bse_code": 524715,
            "isin": "INE044A01036",
            "ann_type": "General_Announcements",
            "descriptor": "Press Release / Media Release",
            "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release",
            "news_body": "Press Releases",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6d596d3f-6af1-459b-8b20-079a820d8caa.pdf",
            "news_date": "2025-11-12 16:04:32"
        },
        {
            "co_code": 4325,
            "bse_code": 524715,
            "isin": "INE044A01036",
            "ann_type": "General_Announcements",
            "descriptor": "Press Release / Media Release",
            "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release",
            "news_body": "Press Release",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=98a66d1c-5943-4bc6-a7e1-2bd2f100bc8a.pdf",
            "news_date": "2025-11-12 08:58:19"
        },
        {
            "sym": "SUNPHARMA",
            "disp": "Sun Pharmaceutical",
            "bse_code": 524715,
            "isin": "INE044A01036",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Q2 FY26 Earnings Call Transcript",
            "news_id": "e26ec7d2-55b4-48cd-b724-f1f69f2d1fad",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=97dcb020-6882-4de1-8e04-97d06256d293.pdf",
            "news_date": "2025-11-11 16:00:05",
            "seo": "sun-pharmaceutical-ltd",
            "ltp": 1711.1,
            "ch": 3.2999999999999545,
            "pch": 0.19323105750087566,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3351,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 4325,
            "bse_code": 524715,
            "isin": "INE044A01036",
            "ann_type": "General_Announcements",
            "descriptor": "Earnings Call Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Q2 FY26 Earnings Call Transcript",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=97dcb020-6882-4de1-8e04-97d06256d293.pdf",
            "news_date": "2025-11-11 16:00:05"
        },
        {
            "co_code": 4325,
            "bse_code": 524715,
            "isin": "INE044A01036",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
            "news_body": "Intimation of Schedule of Analyst/Institutional Investor Meeting",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=981a48fa-9bce-46bb-b883-18547111e8bc.pdf",
            "news_date": "2025-11-10 17:04:12"
        },
        {
            "co_code": 4325,
            "bse_code": 524715,
            "isin": "INE044A01036",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
            "news_body": "Intimation of Schedule of Analyst/Institutional Investor Meeting",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=82c9d988-ac3e-406c-9a1c-8b5470c915e7.pdf",
            "news_date": "2025-11-07 19:47:23"
        },
        {
            "co_code": 4325,
            "bse_code": 524715,
            "isin": "INE044A01036",
            "ann_type": "General_Announcements",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "Newspaper Publication",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=df4e2007-a588-46c2-aff8-cdd5c1e765eb.pdf",
            "news_date": "2025-11-06 12:01:04"
        },
        {
            "sym": "SUNPHARMA",
            "disp": "Sun Pharmaceutical",
            "bse_code": 524715,
            "isin": "INE044A01036",
            "descriptor": "General",
            "cat": "Audio",
            "caption": "Investor Call Audio Recording",
            "news_body": "Investor Call Audio Recording",
            "news_id": "44c50472-487a-4e61-874e-9c0dba0f9b62",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=12a54720-8836-40fc-840f-875a4672d699.pdf",
            "news_date": "2025-11-05 20:30:41",
            "seo": "sun-pharmaceutical-ltd",
            "ltp": 1711.1,
            "ch": 3.2999999999999545,
            "pch": 0.19323105750087566,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3351,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 4325,
            "bse_code": 524715,
            "isin": "INE044A01036",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Investor Call Audio Recording",
            "news_body": "Investor Call Audio Recording",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=12a54720-8836-40fc-840f-875a4672d699.pdf",
            "news_date": "2025-11-05 20:30:41"
        },
        {
            "co_code": 4325,
            "bse_code": 524715,
            "isin": "INE044A01036",
            "ann_type": "General_Announcements",
            "descriptor": "Amendments to Memorandum & Articles of Association",
            "caption": "Announcement under Regulation 30 (LODR)-Amendments to Memorandum & Articles of Association",
            "news_body": "Board has approved the proposal for alteration of the Memorandum of Association",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3d5e93d0-17f4-4d4b-b11a-cd6fa052a983.pdf",
            "news_date": "2025-11-05 16:21:42"
        },
        {
            "sym": "SUNPHARMA",
            "disp": "Sun Pharmaceutical",
            "bse_code": 524715,
            "isin": "INE044A01036",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Financial Results For The Quarter And Half-Year Ended 30 September 2025",
            "news_body": "Financial Results for the quarter and half-year ended 30 September 2025",
            "news_id": "dd3ed724-bccd-4f79-a747-33862a544fb3",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=962c537c-a0c8-4613-98b2-cbcdcac6ce9e.pdf",
            "news_date": "2025-11-05 16:05:00",
            "seo": "sun-pharmaceutical-ltd",
            "ltp": 1711.1,
            "ch": 3.2999999999999545,
            "pch": 0.19323105750087566,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3351,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 4325,
            "bse_code": 524715,
            "isin": "INE044A01036",
            "ann_type": "Outcome",
            "descriptor": "Financial Results",
            "caption": "Financial Results For The Quarter And Half-Year Ended 30 September 2025",
            "news_body": "Financial Results for the quarter and half-year ended 30 September 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=962c537c-a0c8-4613-98b2-cbcdcac6ce9e.pdf",
            "news_date": "2025-11-05 16:05:00"
        },
        {
            "co_code": 4325,
            "bse_code": 524715,
            "isin": "INE044A01036",
            "ann_type": "General_Announcements",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "Newspaper Advertisements",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=66956f9e-2f5c-4b99-a22b-b723f8592ef8.pdf",
            "news_date": "2025-10-31 18:27:53"
        },
        {
            "co_code": 4325,
            "bse_code": 524715,
            "isin": "INE044A01036",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
            "news_body": "Earnings call for the financial results of the second quarter on 05 November 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f6350c30-186c-48c9-b4b1-24da17a22fcd.pdf",
            "news_date": "2025-10-15 14:25:55"
        },
        {
            "co_code": 4325,
            "bse_code": 524715,
            "isin": "INE044A01036",
            "ann_type": "Intimation",
            "descriptor": "Board Meeting",
            "caption": "Board Meeting Intimation for Approval Of Unaudited Financial Results For The Quarter And Half Year Ended 30 September 2025.",
            "news_body": "Sun Pharmaceutical Industries Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/11/2025 inter alia to consider and approve Unaudited Financial Results for the quarter and half year ended 30 September 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2ecc46b0-c553-471f-9c6e-e93829e3d94f.pdf",
            "news_date": "2025-10-14 17:51:37"
        },
        {
            "co_code": 4325,
            "bse_code": 524715,
            "isin": "INE044A01036",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "ESG Overview For FY 2024-25",
            "news_body": "ESG Overview for FY 2024-25",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b8ec2173-5689-46ea-8333-ec0e2b1252bc.pdf",
            "news_date": "2025-10-14 16:48:03"
        },
        {
            "co_code": 4325,
            "bse_code": 524715,
            "isin": "INE044A01036",
            "ann_type": "General_Announcements",
            "descriptor": "Scheme of Arrangement",
            "caption": "Announcement under Regulation 30 (LODR)-Scheme of Arrangement",
            "news_body": "NCLT approves the Composite Scheme of Arrangement.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=28602a56-a8eb-4622-9ea2-b7c472086688.pdf",
            "news_date": "2025-10-08 20:23:07"
        },
        {
            "co_code": 4325,
            "bse_code": 524715,
            "isin": "INE044A01036",
            "ann_type": "General_Announcements",
            "descriptor": "Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
            "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
            "news_body": "Compliance Certificate under Reg. 74(5) of SEBI (DP) Regulations 2018",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=dd74f694-678d-400a-950a-5e042e41ba84.pdf",
            "news_date": "2025-10-07 14:39:27"
        },
        {
            "co_code": 4325,
            "bse_code": 524715,
            "isin": "INE044A01036",
            "ann_type": "General_Announcements",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "Newspaper Advertisements for 100 Days Campaign - Saksham Niveshak",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f925550d-8def-4ea7-8d29-5d83a7342102.pdf",
            "news_date": "2025-09-24 18:01:56"
        },
        {
            "co_code": 4325,
            "bse_code": 524715,
            "isin": "INE044A01036",
            "ann_type": "Intimation",
            "descriptor": "Closure of Trading Window",
            "caption": "Closure of Trading Window",
            "news_body": "Trading Window Closure for Quarter and half year ended 30 September 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=28b4c916-838f-40d0-8026-2c3f6b762efa.pdf",
            "news_date": "2025-09-22 16:46:36"
        },
        {
            "co_code": 4325,
            "bse_code": 524715,
            "isin": "INE044A01036",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
            "news_body": "Intimation of the Schedule of Analyst Meeting",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f3888496-204a-4188-a15a-90d8e2b30c41.pdf",
            "news_date": "2025-09-18 16:25:00"
        },
        {
            "co_code": 4325,
            "bse_code": 524715,
            "isin": "INE044A01036",
            "ann_type": "General",
            "descriptor": "Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations 2011",
            "caption": "Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations 2011.",
            "news_body": "The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 on September 09 2025 for Raksha Sudhir Valia",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=827D0467_5784_40FB_8E6E_B4E38711E361_114053.pdf",
            "news_date": "2025-09-10 11:40:59"
        },
        {
            "co_code": 4325,
            "bse_code": 524715,
            "isin": "INE044A01036",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Update On US FDA Inspection At Sun Pharma Halol Facility",
            "news_body": "Update on US FDA Inspection at Sun Pharma Halol Facility",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f24488bb-b143-475a-84ac-6d1e152d874c.pdf",
            "news_date": "2025-09-09 20:26:09"
        },
        {
            "co_code": 4325,
            "bse_code": 524715,
            "isin": "INE044A01036",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
            "news_body": "Intimation of Schedule of Analyst/Institutional Investor Meeting",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e36216f9-c70d-4be8-ac7c-6ccd2ddba165.pdf",
            "news_date": "2025-09-08 17:28:15"
        },
        {
            "sym": "SUNPHARMA",
            "disp": "Sun Pharmaceutical",
            "bse_code": 524715,
            "isin": "INE044A01036",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation -Aug 2025",
            "news_id": "d9a935c9-b4c8-44ad-8601-3550a0590b9b",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=53bd47d5-f08c-4abf-89dc-c111d452ca8e.pdf",
            "news_date": "2025-09-01 17:34:12",
            "seo": "sun-pharmaceutical-ltd",
            "ltp": 1711.1,
            "ch": 3.2999999999999545,
            "pch": 0.19323105750087566,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3351,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 4325,
            "bse_code": 524715,
            "isin": "INE044A01036",
            "ann_type": "General_Announcements",
            "descriptor": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation -Aug 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=53bd47d5-f08c-4abf-89dc-c111d452ca8e.pdf",
            "news_date": "2025-09-01 17:34:12"
        },
        {
            "co_code": 4325,
            "bse_code": 524715,
            "isin": "INE044A01036",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
            "news_body": "Intimation of Schedule of Analyst/Institutional Investor Meeting",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=cdd23b9c-0542-4596-8d8f-5c1dab275679.pdf",
            "news_date": "2025-08-25 18:38:15"
        },
        {
            "co_code": 4325,
            "bse_code": 524715,
            "isin": "INE044A01036",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
            "news_body": "Intimation of Schedule of Analyst/Institutional Investor Meeting",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=35c58df7-be7f-4cda-9211-772c6c3e557a.pdf",
            "news_date": "2025-08-12 15:19:15"
        },
        {
            "sym": "SUNPHARMA",
            "disp": "Sun Pharmaceutical",
            "bse_code": 524715,
            "isin": "INE044A01036",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Q1 FY26 Earnings Call Transcript",
            "news_id": "2a9fa3a5-0c93-4cab-8235-39b10a607026",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e9f2ef68-3852-4c76-b699-37803a05f264.pdf",
            "news_date": "2025-08-06 16:55:57",
            "seo": "sun-pharmaceutical-ltd",
            "ltp": 1711.1,
            "ch": 3.2999999999999545,
            "pch": 0.19323105750087566,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3351,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 4325,
            "bse_code": 524715,
            "isin": "INE044A01036",
            "ann_type": "General_Announcements",
            "descriptor": "Earnings Call Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Q1 FY26 Earnings Call Transcript",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e9f2ef68-3852-4c76-b699-37803a05f264.pdf",
            "news_date": "2025-08-06 16:55:57"
        },
        {
            "co_code": 4325,
            "bse_code": 524715,
            "isin": "INE044A01036",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
            "news_body": "Intimation of Schedule of Analyst/Institutional Investor Meeting\r\n\r\n",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=56120297-b741-4f96-8560-1791b3879821.pdf",
            "news_date": "2025-08-05 14:47:27"
        },
        {
            "co_code": 4325,
            "bse_code": 524715,
            "isin": "INE044A01036",
            "ann_type": "General",
            "descriptor": "Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations 2011",
            "caption": "Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations 2011.",
            "news_body": "The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 on August 02 2025 for Raksha Sudhir Valia",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=DF5335BB_AF2F_4BB2_9269_469C8022D7D8_102054.pdf",
            "news_date": "2025-08-04 10:20:57"
        },
        {
            "co_code": 4325,
            "bse_code": 524715,
            "isin": "INE044A01036",
            "ann_type": "General_Announcements",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "Newspaper Advertisement for publication of financial",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d267542d-36e3-44c1-9e1b-f70f40db4290.pdf",
            "news_date": "2025-08-01 18:58:11"
        },
        {
            "co_code": 4325,
            "bse_code": 524715,
            "isin": "INE044A01036",
            "ann_type": "General_Announcements",
            "descriptor": "GENERAL",
            "caption": "Rumour verification - Regulation 30(11)",
            "news_body": "Response to the clarification sought by the BSE Limited",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=72cec2a8-bf16-45d6-b2f3-66b44f4aec5d.pdf",
            "news_date": "2025-08-01 16:35:24"
        },
        {
            "co_code": 4325,
            "bse_code": 524715,
            "isin": "INE044A01036",
            "ann_type": "General",
            "descriptor": "Clarification",
            "caption": "Clarification sought from Sun Pharmaceutical Industries Ltd",
            "news_body": "The Exchange has sought clarification from Sun Pharmaceutical Industries Ltd on August 1 2025 with reference to news appeared in https://www.moneycontrol.com dated August 1 2025 quoting \"Pharma stocks slump as Trump shoots letters to 17 global drug majors seeking lower prices\".<BR><BR>The reply is awaited.",
            "file_url": "",
            "news_date": "2025-08-01 13:28:11"
        },
        {
            "sym": "SUNPHARMA",
            "disp": "Sun Pharmaceutical",
            "bse_code": 524715,
            "isin": "INE044A01036",
            "descriptor": "General",
            "cat": "Audio",
            "caption": "Sun Pharmas Q1FY26 Investor Call Audio Recording",
            "news_body": "Sun Pharmas Q1FY26 Investor Call Audio Recording",
            "news_id": "d23fd9e1-05fd-4abc-bdbe-63769fb1ffdf",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e66f48fa-6352-44dd-9294-df434c2faa89.pdf",
            "news_date": "2025-07-31 20:32:23",
            "seo": "sun-pharmaceutical-ltd",
            "ltp": 1711.1,
            "ch": 3.2999999999999545,
            "pch": 0.19323105750087566,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3351,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 4325,
            "bse_code": 524715,
            "isin": "INE044A01036",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Sun Pharmas Q1FY26 Investor Call Audio Recording",
            "news_body": "Sun Pharmas Q1FY26 Investor Call Audio Recording",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e66f48fa-6352-44dd-9294-df434c2faa89.pdf",
            "news_date": "2025-07-31 20:32:23"
        },
        {
            "co_code": 4325,
            "bse_code": 524715,
            "isin": "INE044A01036",
            "ann_type": "Outcome",
            "descriptor": "AGM",
            "caption": "Shareholder Meeting / Postal Ballot-Outcome of AGM",
            "news_body": "Outcome and proceedings of the 33rd AGM of Sun Pharmaceutical Industries Limited held on 31 July 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4594f2f5-1b1b-4f30-8050-d50c5c4ea311.pdf",
            "news_date": "2025-07-31 19:09:53"
        },
        {
            "sym": "SUNPHARMA",
            "disp": "Sun Pharmaceutical",
            "bse_code": 524715,
            "isin": "INE044A01036",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Financial Results For The Quarter Ended 30 June 2025",
            "news_body": "Financial results for the quarter ended 30 June 2025",
            "news_id": "f2ccb6e8-7dec-4f6d-9470-959f6e019e52",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e83bf6df-02b2-4f7a-b8a7-5beb96ab4ab6.pdf",
            "news_date": "2025-07-31 14:35:42",
            "seo": "sun-pharmaceutical-ltd",
            "ltp": 1711.1,
            "ch": 3.2999999999999545,
            "pch": 0.19323105750087566,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3351,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 4325,
            "bse_code": 524715,
            "isin": "INE044A01036",
            "ann_type": "Outcome",
            "descriptor": "Financial Results",
            "caption": "Financial Results For The Quarter Ended 30 June 2025",
            "news_body": "Financial results for the quarter ended 30 June 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e83bf6df-02b2-4f7a-b8a7-5beb96ab4ab6.pdf",
            "news_date": "2025-07-31 14:35:42"
        },
        {
            "co_code": 4325,
            "bse_code": 524715,
            "isin": "INE044A01036",
            "ann_type": "Outcome",
            "descriptor": "Outcome of Board Meeting",
            "caption": "Board Meeting Outcome for Outcome Of The Board Meeting",
            "news_body": "Outcome of Board Meeting",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a1977c27-bbf5-4b19-bfce-3d0d8c463223.pdf",
            "news_date": "2025-07-31 14:31:44"
        },
        {
            "co_code": 4325,
            "bse_code": 524715,
            "isin": "INE044A01036",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Execution Of Settlement Agreement In The In Re Generic Pharmaceuticals Pricing Antitrust Litigation",
            "news_body": "Intimation about Settlement Agreement",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=01b1342d-bd90-432b-a658-81f9462c87e5.pdf",
            "news_date": "2025-07-24 16:47:46"
        },
        {
            "co_code": 4325,
            "bse_code": 524715,
            "isin": "INE044A01036",
            "ann_type": "General_Announcements",
            "descriptor": "Press Release / Media Release",
            "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release",
            "news_body": "Intimation of Press Release",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a1e61780-abce-4dd4-a020-66cd33fa8da7.pdf",
            "news_date": "2025-07-21 08:25:52"
        },
        {
            "co_code": 4325,
            "bse_code": 524715,
            "isin": "INE044A01036",
            "ann_type": "General_Announcements",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "Newspaper Publication for a special window only for re-lodgement of transfer deed",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f9a8b6b5-70fe-4eee-b842-5348d1384ce3.pdf",
            "news_date": "2025-07-19 14:04:53"
        },
        {
            "co_code": 4325,
            "bse_code": 524715,
            "isin": "INE044A01036",
            "ann_type": "General_Announcements",
            "descriptor": "Acquisition",
            "caption": "Announcement under Regulation 30 (LODR)-Acquisition",
            "news_body": "Intimation of incorporation of a subsidiary company in China.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=091b5ae5-0cb9-411e-9b31-18d78ea3dcf7.pdf",
            "news_date": "2025-07-17 18:14:31"
        },
        {
            "co_code": 4325,
            "bse_code": 524715,
            "isin": "INE044A01036",
            "ann_type": "General_Announcements",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "Newspaper Advertisement",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9a6bc9da-93fe-4b75-8a7e-0ae5b1d628ac.pdf",
            "news_date": "2025-07-15 16:36:05"
        },
        {
            "sym": "SUNPHARMA",
            "disp": "Sun Pharmaceutical",
            "bse_code": 524715,
            "isin": "INE044A01036",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "SPIL Investor Presentation -July 2025",
            "news_id": "5e69baee-6e2d-40cf-8f8c-c02cd6bd8054",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=811dac05-9dcf-4c75-8db4-54806ab875d4.pdf",
            "news_date": "2025-07-14 18:48:59",
            "seo": "sun-pharmaceutical-ltd",
            "ltp": 1711.1,
            "ch": 3.2999999999999545,
            "pch": 0.19323105750087566,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3351,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 4325,
            "bse_code": 524715,
            "isin": "INE044A01036",
            "ann_type": "General_Announcements",
            "descriptor": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "SPIL Investor Presentation -July 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=811dac05-9dcf-4c75-8db4-54806ab875d4.pdf",
            "news_date": "2025-07-14 18:48:59"
        },
        {
            "co_code": 4325,
            "bse_code": 524715,
            "isin": "INE044A01036",
            "ann_type": "General_Announcements",
            "descriptor": "Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
            "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
            "news_body": "Compliance Certificate",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=361e68c2-8ce6-4954-8bf9-3015b4403955.pdf",
            "news_date": "2025-07-14 17:59:18"
        },
        {
            "co_code": 4325,
            "bse_code": 524715,
            "isin": "INE044A01036",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Sun Pharma Announces Launch Of LEQSELVI\u2122 In The US",
            "news_body": "Launch of the LEQSELVI in the US",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b6324122-f418-4165-9ec1-3b070f5e7937.pdf",
            "news_date": "2025-07-14 16:45:28"
        },
        {
            "co_code": 4325,
            "bse_code": 524715,
            "isin": "INE044A01036",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Sun Pharma Announces Settlement On LEQSELVI\u2122",
            "news_body": "Settlement on LEQSELVI",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=00c7a1bd-e770-425e-b54c-e46708cae279.pdf",
            "news_date": "2025-07-14 16:26:46"
        },
        {
            "co_code": 4325,
            "bse_code": 524715,
            "isin": "INE044A01036",
            "ann_type": "Intimation",
            "descriptor": "Board Meeting",
            "caption": "Board Meeting Intimation for Approval Of Unaudited Financial Results For The Q1 Of FY 2025-26",
            "news_body": "Sun Pharmaceutical Industries Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 31/07/2025 inter alia to consider and approve Unaudited Financial Results for the Q1 of FY 2025-26",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=fe854ab6-a0c1-42ab-b9fb-0b486b6d1e02.pdf",
            "news_date": "2025-07-11 17:34:45"
        },
        {
            "co_code": 4325,
            "bse_code": 524715,
            "isin": "INE044A01036",
            "ann_type": "General",
            "descriptor": "Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations 2011",
            "caption": "Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations 2011.",
            "news_body": "The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 on July 10 2025 for Raksha Sudhir Valia",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=FECC07A8_0493_4F15_9F97_D4096496E75A_163943.pdf",
            "news_date": "2025-07-10 16:39:47"
        },
        {
            "co_code": 4325,
            "bse_code": 524715,
            "isin": "INE044A01036",
            "ann_type": "General_Announcements",
            "descriptor": "Business Responsibility and Sustainability Reporting (BRSR)",
            "caption": "Business Responsibility and Sustainability Reporting (BRSR)",
            "news_body": "Business Responsibility and Sustainability Report for FY 2024-25",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=fc38eee2-c7fa-44bb-81a2-f13c151eff8d.pdf",
            "news_date": "2025-07-04 19:27:15"
        },
        {
            "co_code": 4325,
            "bse_code": 524715,
            "isin": "INE044A01036",
            "ann_type": "Intimation",
            "descriptor": "AGM",
            "caption": "Notice For 33Rd Annual General Meeting Of Sun Pharmaceutical Industries Limited",
            "news_body": "Notice of 33rd Annual General Meeting including Annual Report for FY 2024-25",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=76af1322-862b-4864-a3ca-d2ed8205ccff.pdf",
            "news_date": "2025-07-04 17:56:47"
        },
        {
            "co_code": 4325,
            "bse_code": 524715,
            "isin": "INE044A01036",
            "ann_type": "General_Announcements",
            "descriptor": "Reg. 34 (1) Annual Report",
            "caption": "Reg. 34 (1) Annual Report.",
            "news_body": "Annual Report for FY 2024-25",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=511405ab-48e8-4d89-84af-aaa2e083e816.pdf",
            "news_date": "2025-07-04 17:50:19"
        },
        {
            "co_code": 4325,
            "bse_code": 524715,
            "isin": "INE044A01036",
            "ann_type": "Intimation",
            "descriptor": "Closure of Trading Window",
            "caption": "Closure of Trading Window",
            "news_body": "Intimation regarding Closure of Trading Window for the Quarter ended 30 June 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b6c4c0c4-ac04-47ed-af80-a721a4c50cc9.pdf",
            "news_date": "2025-06-26 18:10:22"
        },
        {
            "co_code": 4325,
            "bse_code": 524715,
            "isin": "INE044A01036",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
            "news_body": "Intimation of schedule of Analyst / Institutional Investor Meeting",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=23603b18-8c6c-43e5-9607-324a3590e4b7.pdf",
            "news_date": "2025-06-25 00:57:37"
        },
        {
            "co_code": 4325,
            "bse_code": 524715,
            "isin": "INE044A01036",
            "ann_type": "General_Announcements",
            "descriptor": "Press Release / Media Release",
            "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release",
            "news_body": "Press Release",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=07056c65-fecd-457c-a61c-5800e0ae5d94.pdf",
            "news_date": "2025-06-24 23:50:30"
        },
        {
            "co_code": 4325,
            "bse_code": 524715,
            "isin": "INE044A01036",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Update On US FDA Halol Inspection",
            "news_body": "Update on US FDA Halol Inspection",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f83ee54e-ae54-45cb-b22c-3acc5d59df20.pdf",
            "news_date": "2025-06-14 02:29:26"
        },
        {
            "co_code": 4325,
            "bse_code": 524715,
            "isin": "INE044A01036",
            "ann_type": "General_Announcements",
            "descriptor": "Change in Directorate",
            "caption": "Announcement under Regulation 30 (LODR)-Change in Directorate",
            "news_body": "Intimation for Change in Managing Director",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=fdca5a59-7d6b-49ad-b9e7-c8d08f61ce2b.pdf",
            "news_date": "2025-06-13 18:00:59"
        },
        {
            "co_code": 4325,
            "bse_code": 524715,
            "isin": "INE044A01036",
            "ann_type": "General",
            "descriptor": "Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations 2011",
            "caption": "Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations 2011.",
            "news_body": "The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 on June 05 2025 for Raksha Sudhir Valia",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=110C760F_3F9A_4220_AFA6_ECE3D0F1B517_153022.pdf",
            "news_date": "2025-06-05 15:30:24"
        },
        {
            "co_code": 4325,
            "bse_code": 524715,
            "isin": "INE044A01036",
            "ann_type": "General_Announcements",
            "descriptor": "Press Release / Media Release",
            "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release",
            "news_body": "Press Release",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7f47dadb-ebba-4c16-b69b-2537b4b23507.pdf",
            "news_date": "2025-06-03 17:14:00"
        },
        {
            "co_code": 4325,
            "bse_code": 524715,
            "isin": "INE044A01036",
            "ann_type": "General_Announcements",
            "descriptor": "Press Release / Media Release",
            "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release",
            "news_body": "Completion of acquisition of Checkpoint Therapeutics",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=86b971af-7dee-4a2a-ac20-567a8f411d69.pdf",
            "news_date": "2025-05-30 19:49:01"
        },
        {
            "co_code": 4325,
            "bse_code": 524715,
            "isin": "INE044A01036",
            "ann_type": "Compliance",
            "descriptor": "Reg.24(A)-Annual Secretarial Compliance",
            "caption": "Compliances-Reg.24(A)-Annual Secretarial Compliance",
            "news_body": "Annual Secretarial Compliance Report for FY 2024-25",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b94ac934-06a2-4cc7-b02e-f9cb9db1a0da.pdf",
            "news_date": "2025-05-30 18:38:20"
        },
        {
            "sym": "SUNPHARMA",
            "disp": "Sun Pharmaceutical",
            "bse_code": 524715,
            "isin": "INE044A01036",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Q4 FY25 Earnings Call Transcript",
            "news_id": "222dabd2-70b1-4810-8fab-fd47a7774ce0",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3466942d-443e-4c97-8148-54b3f242e619.pdf",
            "news_date": "2025-05-29 17:33:06",
            "seo": "sun-pharmaceutical-ltd",
            "ltp": 1711.1,
            "ch": 3.2999999999999545,
            "pch": 0.19323105750087566,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3351,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 4325,
            "bse_code": 524715,
            "isin": "INE044A01036",
            "ann_type": "General_Announcements",
            "descriptor": "Earnings Call Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Q4 FY25 Earnings Call Transcript",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3466942d-443e-4c97-8148-54b3f242e619.pdf",
            "news_date": "2025-05-29 17:33:06"
        },
        {
            "co_code": 4325,
            "bse_code": 524715,
            "isin": "INE044A01036",
            "ann_type": "General_Announcements",
            "descriptor": "Acquisition",
            "caption": "Announcement under Regulation 30 (LODR)-Updates on Acquisition",
            "news_body": "Update on Acquisition",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=428db240-1003-45ae-8981-c68ff71375da.pdf",
            "news_date": "2025-05-23 17:22:55"
        },
        {
            "sym": "SUNPHARMA",
            "disp": "Sun Pharmaceutical",
            "bse_code": 524715,
            "isin": "INE044A01036",
            "descriptor": "General",
            "cat": "Audio",
            "caption": "Investor Audio Call Recording",
            "news_body": "Investor Audio Call Recording",
            "news_id": "f3228dde-4022-4653-8216-1bf8d5e8f580",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9b296a88-054e-4726-bc5e-c9f69697814f.pdf",
            "news_date": "2025-05-22 20:57:14",
            "seo": "sun-pharmaceutical-ltd",
            "ltp": 1711.1,
            "ch": 3.2999999999999545,
            "pch": 0.19323105750087566,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3351,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 4325,
            "bse_code": 524715,
            "isin": "INE044A01036",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Investor Audio Call Recording",
            "news_body": "Investor Audio Call Recording",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9b296a88-054e-4726-bc5e-c9f69697814f.pdf",
            "news_date": "2025-05-22 20:57:14"
        },
        {
            "co_code": 4325,
            "bse_code": 524715,
            "isin": "INE044A01036",
            "ann_type": "Intimation",
            "descriptor": "Record Date",
            "caption": "Intimation Of Record Date For The Purpose Of Final Dividend",
            "news_body": "Record date",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5ff3c646-67e2-48ef-b651-6667d2712504.pdf",
            "news_date": "2025-05-22 17:29:51"
        },
        {
            "sym": "SUNPHARMA",
            "disp": "Sun Pharmaceutical",
            "bse_code": 524715,
            "isin": "INE044A01036",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Audited Financial Results For The Quarter And Year Ended 31 March 2025",
            "news_body": "Audited Financial Results",
            "news_id": "1dc36a44-195e-4850-98f5-4383f67be6c2",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=74b39d7e-b0fa-481a-b99a-827ad86869a7.pdf",
            "news_date": "2025-05-22 17:18:45",
            "seo": "sun-pharmaceutical-ltd",
            "ltp": 1711.1,
            "ch": 3.2999999999999545,
            "pch": 0.19323105750087566,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3351,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 4325,
            "bse_code": 524715,
            "isin": "INE044A01036",
            "ann_type": "Outcome",
            "descriptor": "Financial Results",
            "caption": "Audited Financial Results For The Quarter And Year Ended 31 March 2025",
            "news_body": "Audited Financial Results",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=74b39d7e-b0fa-481a-b99a-827ad86869a7.pdf",
            "news_date": "2025-05-22 17:18:45"
        },
        {
            "co_code": 4325,
            "bse_code": 524715,
            "isin": "INE044A01036",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Intimation Regarding Appointment Of Secretarial Auditor",
            "news_body": "Appointment of Secretarial Auditor",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=640f16a7-c3bc-495a-a7d0-e7722b728e2d.pdf",
            "news_date": "2025-05-22 17:14:32"
        },
        {
            "co_code": 4325,
            "bse_code": 524715,
            "isin": "INE044A01036",
            "ann_type": "Outcome",
            "descriptor": "Dividend",
            "caption": "Corporate Action-Board approves Dividend",
            "news_body": "Board recommended final dividend",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e7687ac4-6271-4693-908c-c0176fa4d9bd.pdf",
            "news_date": "2025-05-22 17:01:21"
        },
        {
            "co_code": 4325,
            "bse_code": 524715,
            "isin": "INE044A01036",
            "ann_type": "General_Announcements",
            "descriptor": "Change in Directorate",
            "caption": "Announcement under Regulation 30 (LODR)-Change in Directorate",
            "news_body": "Change in Directors",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=842ef863-8774-4c79-a091-857fd64951ff.pdf",
            "news_date": "2025-05-22 16:55:01"
        },
        {
            "co_code": 4325,
            "bse_code": 524715,
            "isin": "INE044A01036",
            "ann_type": "Outcome",
            "descriptor": "Outcome of Board Meeting",
            "caption": "Board Meeting Outcome for Outcome Of Board Meeting",
            "news_body": "Outcome of Board Meeting",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1e13a354-10e7-4193-ab1b-8b604d704360.pdf",
            "news_date": "2025-05-22 16:50:54"
        },
        {
            "co_code": 4325,
            "bse_code": 524715,
            "isin": "INE044A01036",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
            "news_body": "Intimation of the schedule of Analyst and Institutional Investor Meeting",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=bf00a549-5769-4ace-a4cb-75823d585629.pdf",
            "news_date": "2025-05-20 20:58:10"
        },
        {
            "co_code": 4325,
            "bse_code": 524715,
            "isin": "INE044A01036",
            "ann_type": "General_Announcements",
            "descriptor": "Press Release / Media Release",
            "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release",
            "news_body": "Intimation of Press Release",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=314a871d-122a-4298-b8f6-5082ec9f2313.pdf",
            "news_date": "2025-05-16 17:47:42"
        },
        {
            "co_code": 4325,
            "bse_code": 524715,
            "isin": "INE044A01036",
            "ann_type": "General_Announcements",
            "descriptor": "Press Release / Media Release",
            "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release",
            "news_body": "Sun Pharma announce fourth quarter results on May 22 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=69e938a5-c495-451b-81c6-716c7261c43f.pdf",
            "news_date": "2025-05-12 19:23:23"
        },
        {
            "co_code": 4325,
            "bse_code": 524715,
            "isin": "INE044A01036",
            "ann_type": "Intimation",
            "descriptor": "Board Meeting",
            "caption": "Board Meeting Intimation for Approval Of Audited Financial Results For The Year Ended 31 March 2025 And Final Dividend If Any",
            "news_body": "Sun Pharmaceutical Industries Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 22/05/2025 inter alia to consider and approve Board Meeting Intimation for approval of audited financial results and Final Dividend if any",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0f6c3754-709f-4f11-8c36-401378a6a35e.pdf",
            "news_date": "2025-05-12 12:40:46"
        },
        {
            "co_code": 4325,
            "bse_code": 524715,
            "isin": "INE044A01036",
            "ann_type": "General_Announcements",
            "descriptor": "Press Release / Media Release",
            "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release",
            "news_body": "Sun Pharma launches corporate brand campaign in India.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b0d5ec57-5d00-4f80-ace2-97ad1a178496.pdf",
            "news_date": "2025-05-08 12:41:16"
        },
        {
            "co_code": 4325,
            "bse_code": 524715,
            "isin": "INE044A01036",
            "ann_type": "General_Announcements",
            "descriptor": "Change in Management",
            "caption": "Announcement under Regulation 30 (LODR)-Change in Management",
            "news_body": "Change in Key Managerial Personnel- Chief Financial Officer",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=51ed859f-936e-4d48-a748-304022ce934f.pdf",
            "news_date": "2025-05-06 19:31:03"
        },
        {
            "co_code": 4325,
            "bse_code": 524715,
            "isin": "INE044A01036",
            "ann_type": "General_Announcements",
            "descriptor": "Press Release / Media Release",
            "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release",
            "news_body": "Intimation regarding press release",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ba6212ef-3d91-49f1-849c-c97a10a6a565.pdf",
            "news_date": "2025-04-24 08:30:33"
        },
        {
            "sym": "SUNPHARMA",
            "disp": "Sun Pharmaceutical",
            "bse_code": 524715,
            "isin": "INE044A01036",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation -Feb 2025",
            "news_id": "4b5d8a56-e9da-428c-b394-948a6437eb3f",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=34807459-abf9-47bd-ae8e-0c309ade4bfc.pdf",
            "news_date": "2025-03-04 17:02:48",
            "seo": "sun-pharmaceutical-ltd",
            "ltp": 1711.1,
            "ch": 3.2999999999999545,
            "pch": 0.19323105750087566,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3351,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SUNPHARMA",
            "disp": "Sun Pharmaceutical",
            "bse_code": 524715,
            "isin": "INE044A01036",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Q3 FY25 Earnings Call Transcript",
            "news_id": "01ea8d52-3bfc-4a5e-83d4-a906a56c665b",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c64727af-4734-40b3-9dd8-dab45dd96e83.pdf",
            "news_date": "2025-02-06 15:24:06",
            "seo": "sun-pharmaceutical-ltd",
            "ltp": 1711.1,
            "ch": 3.2999999999999545,
            "pch": 0.19323105750087566,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3351,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SUNPHARMA",
            "disp": "Sun Pharmaceutical",
            "bse_code": 524715,
            "isin": "INE044A01036",
            "descriptor": "General",
            "cat": "Audio",
            "caption": "Q3FY25 Investor Call Audio Recording",
            "news_body": "Q3 FY25 Investor Call Audio Recording",
            "news_id": "840561da-ae11-45f7-b437-3de674f93d18",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3d9f19cb-9059-4a8e-9733-e086fb69605c.pdf",
            "news_date": "2025-01-31 20:38:21",
            "seo": "sun-pharmaceutical-ltd",
            "ltp": 1711.1,
            "ch": 3.2999999999999545,
            "pch": 0.19323105750087566,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3351,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SUNPHARMA",
            "disp": "Sun Pharmaceutical",
            "bse_code": 524715,
            "isin": "INE044A01036",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Outcome Of The Board Meeting Held Today I.E. January 31 2025",
            "news_body": "Outcome of Board Meeting",
            "news_id": "d0e87c86-9b04-4707-94bc-fda1f90bda36",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=cf1218a0-7999-4c14-9df5-b8ff85b5bd34.pdf",
            "news_date": "2025-01-31 15:12:39",
            "seo": "sun-pharmaceutical-ltd",
            "ltp": 1711.1,
            "ch": 3.2999999999999545,
            "pch": 0.19323105750087566,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3351,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SUNPHARMA",
            "disp": "Sun Pharmaceutical",
            "bse_code": 524715,
            "isin": "INE044A01036",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation -Nov 2024",
            "news_id": "90448497-455e-4dd6-b4a0-e45a61c33197",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=589346d5-d3f2-4e8b-b7fc-6eb84985195c.pdf",
            "news_date": "2024-11-28 18:11:49",
            "seo": "sun-pharmaceutical-ltd",
            "ltp": 1711.1,
            "ch": 3.2999999999999545,
            "pch": 0.19323105750087566,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3351,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SUNPHARMA",
            "disp": "Sun Pharmaceutical",
            "bse_code": 524715,
            "isin": "INE044A01036",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Q2 FY25 Earnings call Transcript",
            "news_id": "dd28d98c-8492-4dca-927b-7dd718ce67b9",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3bef8197-b43b-4a13-8773-13ec2f811511.pdf",
            "news_date": "2024-11-04 18:02:27",
            "seo": "sun-pharmaceutical-ltd",
            "ltp": 1711.1,
            "ch": 3.2999999999999545,
            "pch": 0.19323105750087566,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3351,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SUNPHARMA",
            "disp": "Sun Pharmaceutical",
            "bse_code": 524715,
            "isin": "INE044A01036",
            "descriptor": "General",
            "cat": "Audio",
            "caption": "Q2FY25 Investor Call Audio Recording",
            "news_body": "Q2FY25 Investor Call Audio Recording",
            "news_id": "bfc77359-22f9-4c20-bba4-016f4224a6bd",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f9df09b3-0c74-4ab7-b612-9a338c2f6368.pdf",
            "news_date": "2024-10-28 20:53:28",
            "seo": "sun-pharmaceutical-ltd",
            "ltp": 1711.1,
            "ch": 3.2999999999999545,
            "pch": 0.19323105750087566,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3351,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SUNPHARMA",
            "disp": "Sun Pharmaceutical",
            "bse_code": 524715,
            "isin": "INE044A01036",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Financial Results For The Quarter And Half Year Ended September 30, 2024",
            "news_body": "Financial results for quarter and half year ended September 30, 2024",
            "news_id": "68cd056e-734b-418b-ac20-d1421779cfac",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=89bd56cb-e924-44cb-8e38-401eb373d3ca.pdf",
            "news_date": "2024-10-28 14:38:24",
            "seo": "sun-pharmaceutical-ltd",
            "ltp": 1711.1,
            "ch": 3.2999999999999545,
            "pch": 0.19323105750087566,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3351,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SUNPHARMA",
            "disp": "Sun Pharmaceutical",
            "bse_code": 524715,
            "isin": "INE044A01036",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation",
            "news_id": "276597fa-e403-40f5-bcc3-2fc700ac3962",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d1a69652-c883-440b-9e3f-81881aaf438e.pdf",
            "news_date": "2024-09-30 17:31:30",
            "seo": "sun-pharmaceutical-ltd",
            "ltp": 1711.1,
            "ch": 3.2999999999999545,
            "pch": 0.19323105750087566,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3351,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SUNPHARMA",
            "disp": "Sun Pharmaceutical",
            "bse_code": 524715,
            "isin": "INE044A01036",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "SPIL Q1FY25 Earning Call Trascript",
            "news_id": "f7a470e7-dada-4f1f-968e-5d45d24ece09",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9bca3c3b-b79b-4111-af68-679a2038beae.pdf",
            "news_date": "2024-08-07 19:00:06",
            "seo": "sun-pharmaceutical-ltd",
            "ltp": 1711.1,
            "ch": 3.2999999999999545,
            "pch": 0.19323105750087566,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3351,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SUNPHARMA",
            "disp": "Sun Pharmaceutical",
            "bse_code": 524715,
            "isin": "INE044A01036",
            "descriptor": "General",
            "cat": "Audio",
            "caption": "Investor Call Audio Recording",
            "news_body": "Q1FY25 - Investor Call audio recording",
            "news_id": "19e6714c-adb8-4406-b353-909428b89a66",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ef09dd3f-f956-4b5e-8670-7b9a5f9b82f8.pdf",
            "news_date": "2024-08-01 20:21:55",
            "seo": "sun-pharmaceutical-ltd",
            "ltp": 1711.1,
            "ch": 3.2999999999999545,
            "pch": 0.19323105750087566,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3351,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SUNPHARMA",
            "disp": "Sun Pharmaceutical",
            "bse_code": 524715,
            "isin": "INE044A01036",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Financial Results For Q1 Of FY 2024-25",
            "news_body": "Outcome of Board Meeting",
            "news_id": "3e69dc9b-0a4a-4225-a025-b5095bd9ec60",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2f4547b3-faf6-41d9-8f4d-91c71d429b4f.pdf",
            "news_date": "2024-08-01 14:11:46",
            "seo": "sun-pharmaceutical-ltd",
            "ltp": 1711.1,
            "ch": 3.2999999999999545,
            "pch": 0.19323105750087566,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3351,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SUNPHARMA",
            "disp": "Sun Pharmaceutical",
            "bse_code": 524715,
            "isin": "INE044A01036",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "SPIL-Investor Presentation",
            "news_id": "1177dcd6-7884-43d8-8d46-a7ce04c784b7",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c61aaa1c-2fbc-4700-a3aa-ae2a122aca3d.pdf",
            "news_date": "2024-07-10 16:41:23",
            "seo": "sun-pharmaceutical-ltd",
            "ltp": 1711.1,
            "ch": 3.2999999999999545,
            "pch": 0.19323105750087566,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3351,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SUNPHARMA",
            "disp": "Sun Pharmaceutical",
            "bse_code": 524715,
            "isin": "INE044A01036",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Q4 FY24 Earnings Call Transcript",
            "news_id": "474481a1-6bf9-4405-b124-c28001679db5",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ee40a7ec-017e-41e7-9f33-2453153e8620.pdf",
            "news_date": "2024-05-29 15:56:44",
            "seo": "sun-pharmaceutical-ltd",
            "ltp": 1711.1,
            "ch": 3.2999999999999545,
            "pch": 0.19323105750087566,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3351,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SUNPHARMA",
            "disp": "Sun Pharmaceutical",
            "bse_code": 524715,
            "isin": "INE044A01036",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation -March 2024",
            "news_id": "1ff0343b-b88a-4223-8d84-819198068b87",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ff736ef8-33c8-4fe9-a862-2cf0b401de14.pdf",
            "news_date": "2024-03-14 17:09:19",
            "seo": "sun-pharmaceutical-ltd",
            "ltp": 1711.1,
            "ch": 3.2999999999999545,
            "pch": 0.19323105750087566,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3351,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SUNPHARMA",
            "disp": "Sun Pharmaceutical",
            "bse_code": 524715,
            "isin": "INE044A01036",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "SPIL Q3FY24 Earnings Call Transcript",
            "news_id": "f3410c5e-983e-403a-a16b-cf3ddfc2e93d",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8d1a8ff3-6340-4b43-b2fa-35c24c711620.pdf",
            "news_date": "2024-02-06 18:27:11",
            "seo": "sun-pharmaceutical-ltd",
            "ltp": 1711.1,
            "ch": 3.2999999999999545,
            "pch": 0.19323105750087566,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3351,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SUNPHARMA",
            "disp": "Sun Pharmaceutical",
            "bse_code": 524715,
            "isin": "INE044A01036",
            "descriptor": "General",
            "cat": "Audio",
            "caption": "Q3FY24 Investor Call Audio Recording Link",
            "news_body": "Q3FY24 Investor Call Audio Recording Link",
            "news_id": "2d55fd08-8162-471f-a941-d3e3991b1be9",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f0bcd396-9017-45f6-8a29-f53fcf850ca6.pdf",
            "news_date": "2024-01-31 20:41:08",
            "seo": "sun-pharmaceutical-ltd",
            "ltp": 1711.1,
            "ch": 3.2999999999999545,
            "pch": 0.19323105750087566,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3351,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SUNPHARMA",
            "disp": "Sun Pharmaceutical",
            "bse_code": 524715,
            "isin": "INE044A01036",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Financial Results For The Quarter And Nine Months Ended December 31, 2023",
            "news_body": "Unaudited Financial Results for the quarter and nine months ended December 31, 2023",
            "news_id": "f0ddebe7-69fc-40f9-88ff-a901900cf2aa",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=27fe62a4-23fb-429a-b5b6-9fe74421f880.pdf",
            "news_date": "2024-01-31 14:13:46",
            "seo": "sun-pharmaceutical-ltd",
            "ltp": 1711.1,
            "ch": 3.2999999999999545,
            "pch": 0.19323105750087566,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3351,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SUNPHARMA",
            "disp": "Sun Pharmaceutical",
            "bse_code": 524715,
            "isin": "INE044A01036",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "SPIL Investor Presentation January 2024",
            "news_id": "855c4788-f796-47cf-8922-5dc0b1c8ef03",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=22f3cd0c-85d8-4c55-9983-e0c8b5d3a9fd.pdf",
            "news_date": "2024-01-04 14:29:59",
            "seo": "sun-pharmaceutical-ltd",
            "ltp": 1711.1,
            "ch": 3.2999999999999545,
            "pch": 0.19323105750087566,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3351,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SUNPHARMA",
            "disp": "Sun Pharmaceutical",
            "bse_code": 524715,
            "isin": "INE044A01036",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Q2FY24 Earnings Call Transcript",
            "news_id": "58b5ba86-3f5c-4da2-99ac-6ae4307a43c5",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=788eb9c4-2be4-4e46-a1bc-045cc355fed6.pdf",
            "news_date": "2023-11-08 17:56:50",
            "seo": "sun-pharmaceutical-ltd",
            "ltp": 1711.1,
            "ch": 3.2999999999999545,
            "pch": 0.19323105750087566,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3351,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SUNPHARMA",
            "disp": "Sun Pharmaceutical",
            "bse_code": 524715,
            "isin": "INE044A01036",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Financial Results For The Quarter And Half Year Ended September 30, 2023",
            "news_body": "Outcome of the Board meeting",
            "news_id": "18863a81-02c1-40e5-801b-d3938d84bbe3",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ea1440c2-4c93-499b-9bdf-3432c2d19904.pdf",
            "news_date": "2023-11-01 13:23:28",
            "seo": "sun-pharmaceutical-ltd",
            "ltp": 1711.1,
            "ch": 3.2999999999999545,
            "pch": 0.19323105750087566,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3351,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SUNPHARMA",
            "disp": "Sun Pharmaceutical",
            "bse_code": 524715,
            "isin": "INE044A01036",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation -Sept 2023",
            "news_id": "0e6076ae-15ad-4d70-be40-cb5f8e34847c",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f5893923-3593-415f-a2b6-0e52610a6264.pdf",
            "news_date": "2023-09-11 14:26:19",
            "seo": "sun-pharmaceutical-ltd",
            "ltp": 1711.1,
            "ch": 3.2999999999999545,
            "pch": 0.19323105750087566,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3351,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SUNPHARMA",
            "disp": "Sun Pharmaceutical",
            "bse_code": 524715,
            "isin": "INE044A01036",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Q1 FY24 Earnings Call Transcript",
            "news_id": "f83956bb-6a74-4ce7-8425-772ed884855a",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c02c76d9-0d38-41a3-8a4c-ae60c04d7c6b.pdf",
            "news_date": "2023-08-09 15:08:35",
            "seo": "sun-pharmaceutical-ltd",
            "ltp": 1711.1,
            "ch": 3.2999999999999545,
            "pch": 0.19323105750087566,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3351,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SUNPHARMA",
            "disp": "Sun Pharmaceutical",
            "bse_code": 524715,
            "isin": "INE044A01036",
            "descriptor": "General",
            "cat": "Audio",
            "caption": "Investor Call Audio Recording",
            "news_body": "Investor Call Audio Recording",
            "news_id": "0dcaa35d-a2aa-457d-9fed-c6356d4e5625",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d3fe4868-0822-4781-82d4-58292f7ea21e.pdf",
            "news_date": "2023-08-03 21:11:16",
            "seo": "sun-pharmaceutical-ltd",
            "ltp": 1711.1,
            "ch": 3.2999999999999545,
            "pch": 0.19323105750087566,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3351,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SUNPHARMA",
            "disp": "Sun Pharmaceutical",
            "bse_code": 524715,
            "isin": "INE044A01036",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Financial Results For The Quarter Ended June 30, 2023",
            "news_body": "As per the letter attached.",
            "news_id": "ee958e0f-c2c5-4d09-b181-8bb093b83efd",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d1000850-5ff1-46da-9b87-4a2e91f9c477.pdf",
            "news_date": "2023-08-03 14:05:19",
            "seo": "sun-pharmaceutical-ltd",
            "ltp": 1711.1,
            "ch": 3.2999999999999545,
            "pch": 0.19323105750087566,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3351,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SUNPHARMA",
            "disp": "Sun Pharmaceutical",
            "bse_code": 524715,
            "isin": "INE044A01036",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation -July 2023",
            "news_id": "b98e3407-0437-43ac-ba7a-7465e89b8e7c",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=186c7eb4-fbec-475c-b752-496a796a1850.pdf",
            "news_date": "2023-07-21 12:51:42",
            "seo": "sun-pharmaceutical-ltd",
            "ltp": 1711.1,
            "ch": 3.2999999999999545,
            "pch": 0.19323105750087566,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3351,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SUNPHARMA",
            "disp": "Sun Pharmaceutical",
            "bse_code": 524715,
            "isin": "INE044A01036",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Q4 FY23 Earnings Call Transcript",
            "news_id": "0a3d0cd5-2db3-46ef-a2e7-85713271768a",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=146e73bc-f72d-4970-8bf4-85e4a62ab2f7.pdf",
            "news_date": "2023-05-31 14:26:23",
            "seo": "sun-pharmaceutical-ltd",
            "ltp": 1711.1,
            "ch": 3.2999999999999545,
            "pch": 0.19323105750087566,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3351,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SUNPHARMA",
            "disp": "Sun Pharmaceutical",
            "bse_code": 524715,
            "isin": "INE044A01036",
            "descriptor": "General",
            "cat": "Audio",
            "caption": "Q4FY23 Investor Call Audio Recording",
            "news_body": "Q4FY23 Investor call audio recording",
            "news_id": "b588ba60-0c84-4947-b3e4-74e2cebfd6cc",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ac81949f-514b-4bfc-87a4-5e243ec32526.pdf",
            "news_date": "2023-05-26 21:46:03",
            "seo": "sun-pharmaceutical-ltd",
            "ltp": 1711.1,
            "ch": 3.2999999999999545,
            "pch": 0.19323105750087566,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3351,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SUNPHARMA",
            "disp": "Sun Pharmaceutical",
            "bse_code": 524715,
            "isin": "INE044A01036",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Results For The Quarter And Year Ended March 31, 2023",
            "news_body": "With reference to the intimation of Board meeting submitted on May 11, 2023, we wish to inform you that the Meeting of the Board of Directors of the Company was held today i.e. May 26, 2023 which commenced at 10:40 a.m. and ended at 02:35 p.m., wherein the Board has, inter-alia,  <BR> <BR> 1. Approved Financial Results for the fourth quarter and year ended March 31, 2023 <BR> 2. Recommended Final Dividend for financial year 2022-23",
            "news_id": "5f6f4b02-04f5-43e5-895c-a36e8f2219bd",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2796ea31-ed5a-4b54-b289-67239158f9bf.pdf",
            "news_date": "2023-05-26 14:47:51",
            "seo": "sun-pharmaceutical-ltd",
            "ltp": 1711.1,
            "ch": 3.2999999999999545,
            "pch": 0.19323105750087566,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3351,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SUNPHARMA",
            "disp": "Sun Pharmaceutical",
            "bse_code": 524715,
            "isin": "INE044A01036",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation",
            "news_id": "2b7a4ff4-1dda-4b9a-a2a5-43cad8949032",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8698f2bc-87dd-4f1d-89c3-9e9e378d051d.pdf",
            "news_date": "2023-04-28 17:13:33",
            "seo": "sun-pharmaceutical-ltd",
            "ltp": 1711.1,
            "ch": 3.2999999999999545,
            "pch": 0.19323105750087566,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3351,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SUNPHARMA",
            "disp": "Sun Pharmaceutical",
            "bse_code": 524715,
            "isin": "INE044A01036",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Q3 FY23 Earnings Call Transcript",
            "news_id": "4c11bc96-a05a-4eca-9add-2fd345005c20",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e485b9cb-e649-4a5b-a99b-bdf8198f3bf1.pdf",
            "news_date": "2023-02-01 20:10:52",
            "seo": "sun-pharmaceutical-ltd",
            "ltp": 1711.1,
            "ch": 3.2999999999999545,
            "pch": 0.19323105750087566,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3351,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SUNPHARMA",
            "disp": "Sun Pharmaceutical",
            "bse_code": 524715,
            "isin": "INE044A01036",
            "descriptor": "General",
            "cat": "Audio",
            "caption": "Investor Call Audio Recording",
            "news_body": "Q3FY23 Investor call audio recording",
            "news_id": "8a492eba-896b-44f7-b5f8-7161db3ea72c",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9b41bc75-6e98-45c6-93d3-62780419c83f.pdf",
            "news_date": "2023-02-01 08:27:35",
            "seo": "sun-pharmaceutical-ltd",
            "ltp": 1711.1,
            "ch": 3.2999999999999545,
            "pch": 0.19323105750087566,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3351,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SUNPHARMA",
            "disp": "Sun Pharmaceutical",
            "bse_code": 524715,
            "isin": "INE044A01036",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Financial Results For The Quarter And Nine Months Ended December 31, 2022",
            "news_body": "With reference to the intimation of Board meeting submitted on January 16, 2023, we wish to inform you that the Meeting of the Board of Directors of the Company was held today i.e. January 31, 2023 which commenced at 10:00 a.m. and ended at 01:20 p.m. The Board has, inter-alia,  <BR> <BR> Approved Financial Results for the quarter and nine months ended December 31, 2022 <BR> <BR> Pursuant to Regulation 30 and 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('SEBI Listing Regulations'), we enclose herewith the Unaudited Standalone and Consolidated Financial Results of the Company and its subsidiaries for the quarter and nine months ended December 31, 2022, along with the Limited Review Reports thereon.<BR>",
            "news_id": "a80a59ed-2137-48f6-bfdb-2c1fd3b89037",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e8744cd2-139b-4755-8f0b-fd5b8df9145d.pdf",
            "news_date": "2023-01-31 13:28:22",
            "seo": "sun-pharmaceutical-ltd",
            "ltp": 1711.1,
            "ch": 3.2999999999999545,
            "pch": 0.19323105750087566,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3351,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SUNPHARMA",
            "disp": "Sun Pharmaceutical",
            "bse_code": 524715,
            "isin": "INE044A01036",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "SPIL Investor Presentation",
            "news_id": "c2f28c6d-53fc-4b58-ad3d-9b8cde6e88d1",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a746248f-0105-4089-98c4-ba102ee0cc86.pdf",
            "news_date": "2023-01-16 16:47:52",
            "seo": "sun-pharmaceutical-ltd",
            "ltp": 1711.1,
            "ch": 3.2999999999999545,
            "pch": 0.19323105750087566,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3351,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SUNPHARMA",
            "disp": "Sun Pharmaceutical",
            "bse_code": 524715,
            "isin": "INE044A01036",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Intimation Under Regulation 23(9) Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015",
            "news_body": "Pursuant to Regulation 23(9) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the disclosure of related party transactions for the half year ended September 30, 2022 is enclosed herewith.",
            "news_id": "0939a630-1a8d-438d-9eea-93351fb583b4",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=85f1bb55-6b0e-4112-a72e-2f0f543dcc75.pdf",
            "news_date": "2022-11-16 12:23:36",
            "seo": "sun-pharmaceutical-ltd",
            "ltp": 1711.1,
            "ch": 3.2999999999999545,
            "pch": 0.19323105750087566,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3351,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SUNPHARMA",
            "disp": "Sun Pharmaceutical",
            "bse_code": 524715,
            "isin": "INE044A01036",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Transcript of the Company's Q2FY23 earnings conference call.",
            "news_id": "ba1908f6-3d88-4932-999d-8f8ded0fe88e",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5ce16a4d-da5c-414e-ae88-048e3e9386e0.pdf",
            "news_date": "2022-11-05 21:26:02",
            "seo": "sun-pharmaceutical-ltd",
            "ltp": 1711.1,
            "ch": 3.2999999999999545,
            "pch": 0.19323105750087566,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3351,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SUNPHARMA",
            "disp": "Sun Pharmaceutical",
            "bse_code": 524715,
            "isin": "INE044A01036",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Results For The Quarter And Half Year Ended September 30, 2022",
            "news_body": "With reference to the intimation of Board meeting submitted on October 10, 2022, we wish to inform you that the Meeting of the Board of Directors of the Company was held today i.e. November 01, 2022 which commenced at 10:10 am and ended at 01:10 pm. The Board has, inter-alia,  <BR> <BR> 1.  Approved Financial Results for the quarter and half year ended September 30, 2022 <BR> <BR> 2.  Approved and recommended Appointment of Independent Director",
            "news_id": "01e47abe-a133-4cea-a619-d51e8179acab",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5f6804da-f8c1-4896-99f5-d6d3159f0e9c.pdf",
            "news_date": "2022-11-01 13:36:13",
            "seo": "sun-pharmaceutical-ltd",
            "ltp": 1711.1,
            "ch": 3.2999999999999545,
            "pch": 0.19323105750087566,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3351,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SUNPHARMA",
            "disp": "Sun Pharmaceutical",
            "bse_code": 524715,
            "isin": "INE044A01036",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Please find enclosed herewith the investor presentation, which we shall be uploading on our website after sending this letter to you.",
            "news_id": "1a5381a0-73b6-4c7f-8d69-98c11313faf1",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1917fd81-3d5b-4335-86c8-e03a677b571c.pdf",
            "news_date": "2022-09-16 17:04:20",
            "seo": "sun-pharmaceutical-ltd",
            "ltp": 1711.1,
            "ch": 3.2999999999999545,
            "pch": 0.19323105750087566,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3351,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SUNPHARMA",
            "disp": "Sun Pharmaceutical",
            "bse_code": 524715,
            "isin": "INE044A01036",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Transcript of the Company's Q1FY23 earnings conference call.",
            "news_id": "6ff8850e-6174-4547-9509-de6d4d9816e7",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4d6dc697-3de4-4ebd-98c7-bb4a1eae4f4c.pdf",
            "news_date": "2022-08-03 16:56:21",
            "seo": "sun-pharmaceutical-ltd",
            "ltp": 1711.1,
            "ch": 3.2999999999999545,
            "pch": 0.19323105750087566,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3351,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SUNPHARMA",
            "disp": "Sun Pharmaceutical",
            "bse_code": 524715,
            "isin": "INE044A01036",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Financial Results For The Quarter Ended June 30, 2022",
            "news_body": "With reference to the intimation of Board meeting submitted on July 12, 2022, we wish to inform you that the Meeting of the Board of Directors of the Company was held today i.e. July 29, 2022 which commenced at 10:00 a.m. IST and ended at 01:25 p.m. IST. <BR> <BR> The Board has, inter-alia, approved Unaudited Standalone and Consolidated Financial Results for the quarter ended June 30, 2022.<BR>",
            "news_id": "0f41b831-2758-45de-ba3a-01d15a9d851d",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7f7efda3-62da-4ce9-b004-f00c659cae57.pdf",
            "news_date": "2022-07-29 13:39:06",
            "seo": "sun-pharmaceutical-ltd",
            "ltp": 1711.1,
            "ch": 3.2999999999999545,
            "pch": 0.19323105750087566,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3351,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SUNPHARMA",
            "disp": "Sun Pharmaceutical",
            "bse_code": 524715,
            "isin": "INE044A01036",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Intimation Under Regulation 23(9) Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015",
            "news_body": "Pursuant to Regulation 23(9) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the disclosure of related party transactions (on consolidated basis) for the half year ended March 31, 2022 is enclosed herewith.",
            "news_id": "2b5400d7-e3c4-41e2-99d0-27480a5599bb",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a7c5af49-8657-44bc-bdd8-3d249da3f695.pdf",
            "news_date": "2022-06-14 17:51:45",
            "seo": "sun-pharmaceutical-ltd",
            "ltp": 1711.1,
            "ch": 3.2999999999999545,
            "pch": 0.19323105750087566,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3351,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SUNPHARMA",
            "disp": "Sun Pharmaceutical",
            "bse_code": 524715,
            "isin": "INE044A01036",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Transcript of the Company's Q4FY22 earnings conference call.",
            "news_id": "95fbd1c9-545f-4b6c-9402-f2b586d1d98a",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=29210495-3f9c-418e-ae83-9e7328b8e485.pdf",
            "news_date": "2022-06-02 18:08:02",
            "seo": "sun-pharmaceutical-ltd",
            "ltp": 1711.1,
            "ch": 3.2999999999999545,
            "pch": 0.19323105750087566,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3351,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SUNPHARMA",
            "disp": "Sun Pharmaceutical",
            "bse_code": 524715,
            "isin": "INE044A01036",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Q4FY22 Earnings Call Audio Recording",
            "news_id": "84e227f2-3108-43eb-ad6c-8cb92f7b0a92",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=27d1b97d-a6dd-4b51-adf9-920f9331539d.pdf",
            "news_date": "2022-05-30 21:36:23",
            "seo": "sun-pharmaceutical-ltd",
            "ltp": 1711.1,
            "ch": 3.2999999999999545,
            "pch": 0.19323105750087566,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3351,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SUNPHARMA",
            "disp": "Sun Pharmaceutical",
            "bse_code": 524715,
            "isin": "INE044A01036",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Results For The Year Ended March 31, 2022",
            "news_body": "Attached",
            "news_id": "560baf21-b190-4115-ae7e-8328a21fcf55",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b974b285-f201-434a-8777-6b19699f34b3.pdf",
            "news_date": "2022-05-30 15:30:44",
            "seo": "sun-pharmaceutical-ltd",
            "ltp": 1711.1,
            "ch": 3.2999999999999545,
            "pch": 0.19323105750087566,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3351,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SUNPHARMA",
            "disp": "Sun Pharmaceutical",
            "bse_code": 524715,
            "isin": "INE044A01036",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Please find enclosed herewith the investor presentation.",
            "news_id": "a6aca996-ebc0-48af-a07d-17dddf068129",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=339a0c90-0174-4550-afb8-583c664106d2.pdf",
            "news_date": "2022-03-24 16:12:57",
            "seo": "sun-pharmaceutical-ltd",
            "ltp": 1711.1,
            "ch": 3.2999999999999545,
            "pch": 0.19323105750087566,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3351,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SUNPHARMA",
            "disp": "Sun Pharmaceutical",
            "bse_code": 524715,
            "isin": "INE044A01036",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Transcript of the Company's Q3FY22 earnings conference call.",
            "news_id": "03b2e1f4-5aa2-4658-96f8-fafb0091a692",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c96f5127-18f1-4664-8ac5-5cca09a0d4be.pdf",
            "news_date": "2022-02-03 17:33:51",
            "seo": "sun-pharmaceutical-ltd",
            "ltp": 1711.1,
            "ch": 3.2999999999999545,
            "pch": 0.19323105750087566,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3351,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SUNPHARMA",
            "disp": "Sun Pharmaceutical",
            "bse_code": 524715,
            "isin": "INE044A01036",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "1. Approval Of Unaudited Financial Statements For The Quarter And Nine Months Ended December 31, 2021;<BR> 2. Declaration Of An Interim Dividend For The Financial Year Ending On March 31, 2022 And Fixing Of Record Date For The Same.<BR> 3. & 4. Change In The Company Secretary & Compliance Officer Of The Company",
            "news_body": "As per the letter attached",
            "news_id": "22002cf0-e0f9-403a-8bd2-e250688b8ccf",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4dd229d6-fef6-4fe4-8844-36cb300f3397.pdf",
            "news_date": "2022-01-31 13:45:10",
            "seo": "sun-pharmaceutical-ltd",
            "ltp": 1711.1,
            "ch": 3.2999999999999545,
            "pch": 0.19323105750087566,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3351,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SUNPHARMA",
            "disp": "Sun Pharmaceutical",
            "bse_code": 524715,
            "isin": "INE044A01036",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Transcript of the Company''s Q2FY22 earnings conference<BR> call.",
            "news_id": "bf771161-0ac7-42a3-b025-b77f4d3279f1",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7a4d3ebd-410c-47fc-964a-76d80ffb8f53.pdf",
            "news_date": "2021-11-11 15:11:35",
            "seo": "sun-pharmaceutical-ltd",
            "ltp": 1711.1,
            "ch": 3.2999999999999545,
            "pch": 0.19323105750087566,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3351,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SUNPHARMA",
            "disp": "Sun Pharmaceutical",
            "bse_code": 524715,
            "isin": "INE044A01036",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Approval Of Unaudited Standalone And Consolidated Financial Results For The Quarter And Half Year Ended September 30, 2021",
            "news_body": "The Board of Directors of the Company at its meeting held today i.e. November 02, 2021 has inter alia considered and approved the Unaudited Standalone and Consolidated Financial Results for the quarter and half year ended September 30, 2021.<BR> Pursuant to Regulation 30 and 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (Listing Regulations), we enclose herewith the following as 'Annexure':<BR> a) Unaudited Standalone and Consolidated Financial Results of the Company for the quarter and half year ended September 30, 2021.<BR> b) Limited  Review  Report  of  the  Statutory  Auditors  of  the  Company  on  Unaudited Standalone and Consolidated Financial Results for the quarter and half year ended September 30, 2021.<BR> The meeting of the Board of Directors of the Company commenced at 10:30 a.m. and concluded at 01:10 p.m.<BR>",
            "news_id": "3fab0ad4-d59b-4175-a65a-553eebe7b882",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=51259527-894f-40ca-81c4-3570cd731c78.pdf",
            "news_date": "2021-11-02 13:28:04",
            "seo": "sun-pharmaceutical-ltd",
            "ltp": 1711.1,
            "ch": 3.2999999999999545,
            "pch": 0.19323105750087566,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3351,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SUNPHARMA",
            "disp": "Sun Pharmaceutical",
            "bse_code": 524715,
            "isin": "INE044A01036",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Approval Of Unaudited Standalone And Consolidated Financial Results For The Quarter And Half Year Ended September 30, 2021",
            "news_body": "The Board of Directors of the Company at its meeting held today i.e. November 02, 2021 has inter alia considered and approved the Unaudited Standalone and Consolidated Financial Results for the quarter and half year ended September 30, 2021.<BR> Pursuant to Regulation 30 and 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (Listing Regulations), we enclose herewith the following as 'Annexure':<BR> a) Unaudited Standalone and Consolidated Financial Results of the Company for the quarter and half year ended September 30, 2021.<BR> b) Limited  Review  Report  of  the  Statutory  Auditors  of  the  Company  on  Unaudited Standalone and Consolidated Financial Results for the quarter and half year ended September 30, 2021.<BR> The meeting of the Board of Directors of the Company commenced at 10:30 a.m. and concluded at 01:10 p.m.<BR>",
            "news_id": "518099d3-8823-4d52-9751-d4300ce13426",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f6433c54-a75b-4bab-9334-b58d00cde3b7.pdf",
            "news_date": "2021-11-02 13:15:58",
            "seo": "sun-pharmaceutical-ltd",
            "ltp": 1711.1,
            "ch": 3.2999999999999545,
            "pch": 0.19323105750087566,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3351,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SUNPHARMA",
            "disp": "Sun Pharmaceutical",
            "bse_code": 524715,
            "isin": "INE044A01036",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Please find enclosed herewith a copy of the transcript of the Company's Q1FY22 earnings conference call.",
            "news_id": "2a6af7c7-08bb-44bb-8e98-56043aa5ca1c",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=11d850b2-ea51-4b85-b41a-6fbe75675d86.pdf",
            "news_date": "2021-08-06 15:37:47",
            "seo": "sun-pharmaceutical-ltd",
            "ltp": 1711.1,
            "ch": 3.2999999999999545,
            "pch": 0.19323105750087566,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3351,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SUNPHARMA",
            "disp": "Sun Pharmaceutical",
            "bse_code": 524715,
            "isin": "INE044A01036",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Approval Of Unaudited Standalone And Consolidated Financial Results For The Quarter Ended June 30, 2021",
            "news_body": "The Board of Directors of the Company at its meeting held today i.e. July 30, 2021 has inter alia considered and approved the Unaudited Standalone and Consolidated Financial Results for the quarter ended June 30, 2021.<BR> <BR> Pursuant to Regulation 30 and 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('Listing Regulations'), we enclose herewith the following as 'Annexure':  <BR> <BR> a) Unaudited (Standalone and Consolidated) Financial Results of the Company for the quarter ended June 30, 2021. <BR> <BR> b) Limited Review Report of the Statutory Auditors of the Company on Unaudited (Standalone and Consolidated) Financial Results for the quarter  ended June 30, 2021. <BR>  <BR> The meeting of the Board of Directors of the Company commenced at 10.15 a.m. and concluded at 1:45 p.m.",
            "news_id": "a57f7aed-3ea5-4d9a-9f3f-7166685aa0d1",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4ab06ce7-1913-43dd-ad83-0257e2609d5d.pdf",
            "news_date": "2021-07-30 13:55:38",
            "seo": "sun-pharmaceutical-ltd",
            "ltp": 1711.1,
            "ch": 3.2999999999999545,
            "pch": 0.19323105750087566,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3351,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SUNPHARMA",
            "disp": "Sun Pharmaceutical",
            "bse_code": 524715,
            "isin": "INE044A01036",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Transcript of the Company's Q4FY21 earnings conference call.",
            "news_id": "cd834f18-2498-4af1-aacc-a12e5d08e343",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d619b226-40c2-4d83-b719-81a9d1ced632.pdf",
            "news_date": "2021-06-02 18:02:18",
            "seo": "sun-pharmaceutical-ltd",
            "ltp": 1711.1,
            "ch": 3.2999999999999545,
            "pch": 0.19323105750087566,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3351,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SUNPHARMA",
            "disp": "Sun Pharmaceutical",
            "bse_code": 524715,
            "isin": "INE044A01036",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "1) Approval Of Audited Standalone And Consolidated Financial Statements For The Quarter And Year Ended March 31, 2021.<BR> 2) Recommendation Of Payment Of Final Dividend For The Financial Year Ended March 31, 2021.<BR> <BR>",
            "news_body": "As per letter attached",
            "news_id": "397e3cef-1f16-4e2a-b135-d8b92b089e43",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=194b8268-fc8b-4874-91b1-c2b17a44bf87.pdf",
            "news_date": "2021-05-27 15:55:59",
            "seo": "sun-pharmaceutical-ltd",
            "ltp": 1711.1,
            "ch": 3.2999999999999545,
            "pch": 0.19323105750087566,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3351,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SUNPHARMA",
            "disp": "Sun Pharmaceutical",
            "bse_code": 524715,
            "isin": "INE044A01036",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Result - Audited Financial Results For The Quarter And Year Ended March 31, 2021, Recommended Final Dividend",
            "news_body": "As per letter attached",
            "news_id": "9bc08a5b-af6e-401c-8ff6-8baf7d2a5ba3",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=befc3d37-aa69-43e7-8acd-ad41705845d8.pdf",
            "news_date": "2021-05-27 15:53:13",
            "seo": "sun-pharmaceutical-ltd",
            "ltp": 1711.1,
            "ch": 3.2999999999999545,
            "pch": 0.19323105750087566,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3351,
            "exch": "NSE",
            "seg": "E"
        }
    ]
}